PepLabo Download

Victoza® and bloating

A tight, swollen belly or more wind than usual is a common complaint in the first weeks of a GLP-1 medicine. For Victoza®, the daily liraglutide injection for type 2 diabetes, the US label is silent on bloating, yet the European and Canadian product information both list it. This page puts the figures side by side, explains how a slower stomach fits in, looks at the other causes that matter in diabetes, and lists the signs that need a doctor the same day.

Published · Updated · Victoza®: side effects by symptom · Written by the PepLabo editorial team

Where bloating appears in the product information

The US Table 1 lists reactions seen in at least 5% of adults and more often than on placebo; bloating does not reach it, though dyspepsia (indigestion) does, at 4% on 1.2 mg and 7% on 1.8 mg against 1% on placebo. [1] Europe uses frequency classes instead and puts abdominal distension, flatulence and abdominal discomfort in the common band. [2] Its patient leaflet translates these as a painful or swollen tummy and wind. [2]

Canada’s monograph prints every event above 1% in each trial, which gives actual percentages. [3] They are small and do not always favour the comparison group.

Abdominal distension and flatulence in Victoza® trials (Health Canada monograph, section 8.2; read from the PDF page images)
Trial and termVictoza®Comparison
LEAD-2, 26 weeks, with metformin: distension [3]0.6 mg 0.8%; 1.2 mg 0.8%; 1.8 mg 0.8%Placebo 0.0%; glimepiride 1.7%
LEAD-5, 26 weeks, with metformin and glimepiride: distension [3]1.8 mg 1.3%Placebo 0.9%; insulin glargine 0.4%
Trial 1860, 26 weeks, with metformin: distension [3]1.2 mg 0.9%; 1.8 mg 1.8%Sitagliptin 0.5%
Trial 1860: flatulence [3]1.2 mg 0.9%; 1.8 mg 2.3%Sitagliptin 0.5%
Trial 1842, 52 weeks, 1.8 mg with metformin: distension [3]0.0%; 1.8% with insulin detemir addedNo placebo arm
LEAD-3, 52 weeks, Victoza® alone: flatulence [3]1.2 mg 1.6%; 1.8 mg 5.3%Glimepiride 1.6%
EU frequency class [2]Distension, flatulence, discomfort: common—

Timing: the first weeks and each step up

Victoza® starts at 0.6 mg a day for one week, a step the US label says is there to reduce stomach and bowel reactions and is not meant to control blood sugar. [1] The dose then rises to 1.2 mg and, if needed, to 1.8 mg. [1] Europe says digestive reactions are more frequent at the start and usually ease within a few days or weeks. [2] In the US pool, people who stopped because of digestive reactions mostly did so in the first 2 to 3 months. [1]

Two groups may notice more: Europe states that people over 70 and people with mild or moderate kidney impairment may have more digestive effects on liraglutide. [2] If more than 3 days of doses are missed, the US label says to restart at 0.6 mg to limit digestive reactions. [1]

Why a slower stomach can feel like bloating

The US label states that Victoza® delays gastric emptying, which is also the reason it asks you to tell your care team before surgery or sedation. [1] Food staying longer in the stomach can feel like fullness, pressure and swelling. Europe lists delayed gastric emptying itself as an uncommon reaction. [2]

The effect at Victoza® doses appears modest. In a 5-week crossover study in adults with obesity but no diabetes, emptying over the first hour was 13% slower than placebo on 1.8 mg, a difference that was not statistically significant, and 23% slower on 3 mg; over five hours, both doses were equivalent to placebo. [5] That study did not include people with diabetes, so it is a guide rather than a direct answer for Victoza® users.

NIDDK describes bloating as a feeling of fullness or swelling and distension as a belly that is actually larger than usual; only about half of people with bloating also have distension. [6]

Diabetes, gastroparesis and gallbladder pain

Bloating in type 2 diabetes is not always the medicine. NIDDK names diabetes as the most common known cause of gastroparesis, a condition in which damaged nerves slow the stomach, with fullness, bloating, belching, nausea and upper abdominal pain among its symptoms. [8] The US label says Victoza® is not recommended in severe gastroparesis, so a long history of these symptoms is worth raising before or during treatment. [1]

Gallbladder problems can also start with bloating. Canada’s leaflet describes an inflamed gallbladder as upper abdominal pain after eating, with nausea, bloating and indigestion, especially after a fatty meal. [3] In the LEADER trial, acute gallbladder events occurred in 3.1% on Victoza® and 1.9% on placebo. [1]

Other causes NIDDK lists include swallowed air, foods with carbohydrates the small intestine does not fully digest, constipation, lactose or fructose intolerance, irritable bowel syndrome, coeliac disease and reflux. [6] Constipation is itself a listed Victoza® reaction, at 5% on either dose in the US table against 1% on placebo. [1]

When bloating is a warning sign

The US postmarketing list includes ileus, intestinal obstruction and severe constipation with faecal impaction, and Europe classes intestinal obstruction as rare. [1][2] The EU leaflet describes bowel obstruction as severe constipation with stomach ache, bloating and vomiting. [2] MedlinePlus lists abdominal swelling, fullness, cramping pain, vomiting and being unable to pass gas among obstruction symptoms. [9]

What the sources describe

  • Eat more slowly, sit down to eat, and avoid fizzy drinks, straws, chewing gum and hard sweets to swallow less air. [7]
  • Smaller, more frequent meals are one change NIDDK says a doctor may suggest. [7]
  • Notice whether beans, lentils, broccoli-type vegetables, high-fibre foods, fructose, lactose or sweeteners ending in “-ol” make it worse. [7]
  • Ask your pharmacist or doctor before over-the-counter gas remedies, probiotics or supplements; NIDDK advises checking with your doctor first. [7]
  • Tell your prescriber about stomach symptoms that are severe or will not go away, as the Medication Guide asks. [1]

Victoza® and Saxenda® are registered trademarks of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk A/S.

When to get help

SignWho to contactHow fastSource
Swollen belly with cramping pain and vomiting, or no stool or gas passingUrgent medical careEmergencyMedlinePlus [9]; EU leaflet [2]
Severe stomach pain that will not go away, with or without vomiting, possibly spreading to the backStop Victoza® and call your provider right awayEmergencyMedication Guide [1]
Vomiting for more than an hour, blood or coffee-ground material in vomit, or sudden sharp painGet a doctor’s help right awayEmergencyNIDDK gastroparesis [8]
Upper abdominal pain after meals with fever, yellow skin or eyes, or clay-coloured stoolsCall your providerTodayMedication Guide [1]
Bloating with signs of dehydration: extreme thirst, dark urine, passing less urine, light-headednessSee a doctorTodayNIDDK gastroparesis [8]
Bloating that persists, changes suddenly or comes with weight loss, diarrhoea or constipationTalk to your doctorAt your next appointmentNIDDK gas [6]

Questions

How common is bloating on Victoza®?

Europe classes abdominal distension as common (1 in 100 to 1 in 10). [2] In Canadian trial tables it ranged from 0% to 1.8% on Victoza®, close to the comparison groups. [3]

Does 1.8 mg cause more wind than 1.2 mg?

In two Canadian trials it did: flatulence was 2.3% on 1.8 mg against 0.9% on 1.2 mg in trial 1860, and 5.3% against 1.6% in LEAD-3. [3]

I have had diabetic gastroparesis for years. Does that matter for Victoza®?

Yes. The US label says Victoza® is not recommended in severe gastroparesis because it slows stomach emptying. [1] Bring the diagnosis up with your prescriber.

The bloating came back after I missed a few days. Why?

The US label says that after more than 3 days without a dose, Victoza® is restarted at 0.6 mg to limit digestive reactions on restarting; your prescriber decides the next steps. [1]

Is the bloating on Saxenda® the same as on Victoza®?

Saxenda® uses the same molecule at up to 3 mg and lists abdominal distension in 4.5% against 3% on placebo. [4] Victoza® stops at 1.8 mg, and its own tables show lower rates. [3]

My father on Victoza® is 74 and complains of a full, swollen stomach. Is age a factor?

Europe says people over 70 may have more digestive effects on liraglutide. [2] Pain, vomiting or no bowel movements need prompt medical attention. [9]

Sources

Sources checked on

  1. VICTOZA® (liraglutide) injection Prescribing Information and Medication Guide, Novo Nordisk Revised 10/2025; Medication Guide 05/2025. Sections 2.1, 2.2, 5.6, 5.8, 5.9, 6.1 (Table 1) and 6.2.
  2. Victoza: EPAR – Product Information (SmPC and package leaflet), European Medicines Agency SmPC section 4.8 (Table 1 read from the PDF page image); package leaflet section 4.
  3. VICTOZA® (liraglutide injection) Product Monograph, Novo Nordisk Canada Inc. (Health Canada Drug Product Database) Date of authorization 2025-08-21. Section 8.2 (Tables 1–4 read from the PDF page images) and Patient Medication Information.
  4. SAXENDA® (liraglutide) injection Prescribing Information, Novo Nordisk Revised 02/2026. Section 6.1, Table 2.
  5. van Can J et al. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J Obes 2014 Randomized incomplete crossover trial, 49 adults, 5 weeks; PubMed abstract.
  6. Symptoms & Causes of Gas in the Digestive Tract, NIDDK (NIH) Last reviewed June 2021.
  7. Treatment for Gas in the Digestive Tract, NIDDK (NIH) Last reviewed June 2021.
  8. Symptoms & Causes of Gastroparesis, NIDDK (NIH) Last reviewed January 2018.
  9. Intestinal obstruction and Ileus, MedlinePlus Medical Encyclopedia (U.S. National Library of Medicine)

Set up your lab tonight.

It takes a few minutes. Pep will be waiting.